• Mashup Score: 2
    New ACR RA-ILD Treatment Guidelines – What Were They Smoking!? | RheumNow - 8 month(s) ago

    Rheumatoid arthritis related interstitial lung disease (RA-ILD) is common, with symptomatic RA-ILD affecting approximately 8% of RA patients. Median survival is around 5 years. There is a very limited evidence base supporting treatment and therefore the recent release of ACR guidelines is to be welcomed. However, the published guidelines appear discordant with the best available evidence base. 

    Source: rheumnow.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of EBRheum
      EBRheum

      Blistering editorial from @RichardPAConway, highlighting some of the peculiar recommendations from the recent @ACRheum RA-ILD guidelines Thoroughly enjoyed this; only critique is that he ended too soon, left lots of meat on the bone https://t.co/TdjkHFOdPp

Load More